As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...

Journal of Nuclear Medicine June 2026, jnumed.125.270791; DOI: https://doi.org/10.2967/jnumed.125.270791 ...

Journal of Nuclear Medicine June 2026, jnumed.126.272086; DOI: https://doi.org/10.2967/jnumed.126.272086 ...

Journal of Nuclear Medicine June 2026, jnumed.126.272258; DOI: https://doi.org/10.2967/jnumed.126.272258 ...

Journal of Nuclear Medicine June 2026, jnumed.126.272338; DOI: https://doi.org/10.2967/jnumed.126.272338 ...

Journal of Nuclear Medicine June 2026, jnumed.125.271785; DOI: https://doi.org/10.2967/jnumed.125.271785 ...

Congratulations to all the awardees of this year's JNM Editors' Choice Awards presented at SNMMI Annual Meeting ...

Table of Contents May 27, 2026; Volume Issue supplement 1 2026 SNMMI Annual Meeting Abstracts ...

Objectives To determine iodine biokinetic variation for patients with DTC treated with high dose I-131 therapy after stimulation with rhTSH versus thyroid hormone withdrawal (THW) and devise an ...

One of the early promises of PET was that it would be quantitative (1), as opposed to imaging modalities such as x-ray CT, MRI, or SPECT, in which quantification is more of a challenge than in PET. By ...

Translocator protein (TSPO) is upregulated in activated microglia and thus can serve as a marker of neuroinflammation. Recently, a novel radioligand, 11C- N,N ...

Bronchioloalveolar carcinoma (BAC) is a peripheral, well-differentiated neoplasm typically arising beyond a recognizable bronchus. It has a tendency to spread to the peripheral air spaces using the ...